Select Medical (NYSE:SEM) PT Raised to $40.00

Select Medical (NYSE:SEM) had its price target boosted by investment analysts at Royal Bank of Canada from $36.00 to $40.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has an “outperform” rating on the health services provider’s stock. Royal Bank of Canada’s price target would indicate a potential upside of 22.17% from the stock’s previous close.

Several other equities research analysts have also weighed in on SEM. Benchmark restated a “buy” rating and issued a $39.00 target price on shares of Select Medical in a report on Friday, May 3rd. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, March 22nd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Select Medical presently has a consensus rating of “Moderate Buy” and a consensus target price of $34.80.

Select Medical Stock Performance

SEM stock opened at $32.74 on Monday. The firm has a 50 day moving average of $28.60 and a two-hundred day moving average of $26.07. Select Medical has a 12 month low of $21.28 and a 12 month high of $33.51. The company has a market capitalization of $4.26 billion, a price-to-earnings ratio of 15.59, a P/E/G ratio of 1.24 and a beta of 1.38. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.30.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Friday, February 23rd. The health services provider reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. The firm had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the company posted $0.22 earnings per share. Select Medical’s revenue for the quarter was up 4.9% on a year-over-year basis. As a group, equities analysts anticipate that Select Medical will post 2.03 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Chairman Robert A. Ortenzio sold 50,000 shares of the company’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $26.00, for a total transaction of $1,300,000.00. Following the completion of the transaction, the chairman now owns 6,789,668 shares of the company’s stock, valued at $176,531,368. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 17.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of SEM. Allspring Global Investments Holdings LLC raised its stake in Select Medical by 6.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after acquiring an additional 405 shares in the last quarter. Watershed Asset Management L.L.C. increased its position in shares of Select Medical by 8.2% during the 4th quarter. Watershed Asset Management L.L.C. now owns 10,760 shares of the health services provider’s stock worth $253,000 after purchasing an additional 814 shares in the last quarter. Paralel Advisors LLC lifted its holdings in Select Medical by 1.1% during the 3rd quarter. Paralel Advisors LLC now owns 73,981 shares of the health services provider’s stock valued at $1,870,000 after purchasing an additional 836 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Select Medical by 1.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 47,310 shares of the health services provider’s stock valued at $1,112,000 after buying an additional 858 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new stake in Select Medical during the third quarter worth about $29,000. 89.48% of the stock is owned by institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.